Abstract
Macrophages are a major component of the lymphoreticular infiltrate of rodent and human tumors (Mantovani et al 1992a). Since these cells are situated at the very interface between tumor and host, they may represent a strategically located target for therapeutic intervention. Interest in these cells is stimulated by the knowledge that macrophages have the potential to kill neoplastic cells including drug-resistant variants surviving conventional chemotherapy (Allavena et al 1987).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Allavena, P., Grandi, M., D’Incalci, M., Geri, O., Giuliani, F.C., and Mantovani, A., 1987, Human tumor cell lines with pleiotropic drug resistance are efficiently killed by Interleukin-2 activated killer cells and by activated monocytes. Int. J. Cancer, 40: 104.
Allavena, P., Peccatori, F., Maggioni, D., Sironi, M., Colombo, N., Lissoni, A., Galazka, A., Meiers, W., Mangioni, C., and Mantovani A., 1990, Intraperitoneal recombinant g-interferon in patients with recurrent ascitic ovarian carcinoma: modulation of cytotoxicity and cytokine production in tumor-associated effectors and major histocompatibility antigen expression on tumor cells. Cancer Res., 50: 7318.
Bernasconi, S., Peri G., Sironi, M., and Mantovani, A., 1991, Involvement of leukocyte (B2) integrins (CD18/CD11) in human monocyte tumoricidal activity. Int. J. Cancer, 49: 267.
Bottazzi, B., Polentarutti, N., Acero, R., Balsari, A., Boraschi, D., Ghezzi, P., Salmona, M., and Mantovani, A., 1983, Regulation of the macrophage content of neoplasms by chemoattractants. Science, 220: 210.
Bottazzi, B., Colotta, F., Sica, A., Nobili, N. and Mantovani, A., 1990a, A chemoattractant expressed in human sarcoma cells (Tumor-derived chemotactic factor, TCDF) is identical to monocyte chemoattractant protein- 1/monocyte chemotactic and activating factor (MCP-1/MCAF). Int. J. Cancer, 45: 795.
Bottazzi, B., Erba, E., Nobili, N., Fazioli, F., Rambaldi, A. and Mantovani, A., 1990b, A paracrine circuit in the regulation of the proliferation of macrophages infiltrating murine sarcomas. J. Immunol., 144: 2409.
Bottazzi, B., Walter, S., Govoni, D., Colotta F., and Mantovani, A., 1992, Monocyte chemotactic cytokine gene transfer modulates macrophage infiltration, growth and susceptibility to IL-2 therapy of a murine melanoma. J. Immunol., 148: 1280.
Colombo, N., Peccatori, F., Paganin, C., Bini, S., Brandely, M., Mangioni, C., Mantovani, A., and Allavena, P., 1992, Anti-tumor and immunomodulatory activity of intraperitoneal administration of IFN g in ovarian carcinoma patients with minimal residual tumor after chemotherapy, Int. J. Cancer, in press.
Evans, R., and Cullen, R.T., 1984, In situ proliferation of intratumor macrophages. Journal Leukocyte Biology, 35: 561.
Furutani, Y., Nomura, H., Notake, M., Oyamada, Y., Fukui, T., Yamada, M., Larsen, C.G., Oppenheim, J.J., and Matsushima, K., 1989, Cloning and sequencing of the cDNA for human monocyte chemotactic and activating factor (MCAF). Biochem. biophys. Res. Commun., 159: 248.
Jonjic, N., Jilek, P., Bernasconi, S., Peri, G., Martin-Padura, I., Cenzuales, S., Dejana, E., and Mantovani, A., 1992, Molecules involved in the adhesion and cytotoxicity of activated monocytes on endothelial cells. J. Immunol., 148: 2080.
Mahoney, K.H., and Heppner, G.H., 1987, FACS analysis of tumor associated macrophage replication: Differences between metastatic and nonmetastatic murine mammary tumors. Journal Leukocyte Biology, 41: 205.
Mantovani, A., Bottazzi, B., Colotta, F., Sozzani, S., and Ruco, L., 1992a, Origin and function of tumor-associated macrophages. Immunology Todayin press.
Mantovani, A., Bussolino, F., and Dejana, E., 1992b, Cytokine regulation of endothelial cell function. Faseb J., in press.
Matsushima, K., Larsen, C.G., DuBois, G.C., and Oppenheim, J.J., 1989, Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J. Exp. Med., 169: 1485.
Oppenheim, J.J., Zachariae, C.O.C., Mukaida, N., and Matsushima, K., 1991, Properties of the novel proinfammatoty supergene “Intercrine” cytokine family. Annual Review of Immunol., 9: 617.
Pujade-Lauraine, E., Colombo, N., Namer, N., Fumoleau, P., Monnier, A., Nooy, M.A., Falkson, G., Mignot, L., Bugat, R., Oliveira, C.M.D., Mousseau, M., Netter, G., Oberling, F.,Coiffier, B., and Brandely, M., 1990, Intraperitoneal human r-IFN gamma in patients with residual ovarian carcinoma (OC) at second look laparotomy (SLL). ASCO, 9:156abs., 111.
Sica, A., Wang, J.M., Colotta, F., Dejana, E., Mantovani, A., Oppenheim, J.J., Larsen, C.G., Zachariae, C.O., and Matsushima, K., 1990, Monocyte chemotactic factor gene expression induced in endothelial cells by IL-1 and tumor necrosis factor. J. Immunol., 144: 3034.
Snyderman, R., and Cianciolo, G.J., 1984, Immunosuppressive activity of the retroviral envelope protein P15E and its possible relationship to neoplasia. Immunology Today, 5: 240.
Valente, A.J., Fowler, S.R., Sprague, E.A., Kelley, J.L., Suenram, A.C. and Schwartz, C.J., 1984, Initial characterization of a peripheral blood mononuclear cell chemoattractant derived from cultured arterial smooth muscle cells. Am. J. Pathol., 117: 479.
Van Damme, J., Decock, B., Lenaerts, J.P., Conings, R., Bertini R., Mantovani, A. and Billiau, A., 1989, Identification by sequence analysis of chemotactic factors for monocytes produced by normal and transformed cells stimulated with virus, double stranded RNA or IL-1. Europ. J. Immunol., 19: 2367.
Walter, S., Bottazzi, B., Govoni, D., Colotta, F., and Mantovani, A., 1991, Macrophage infiltration and growth of sarcoma clones expressing different amounts of monocyte chemotactic protein/JE. Int. J. Cancer, 49: 431.
Wang, J.M., Cianciolo, G.J., Snyderman, R., and Mantovani, A., 1986, Coexistence of a chemotactic factor and a retroviral P15E-related chemotaxis inhibitor in human tumor cell culture supernatants. J. Immunol., 137: 2726.
Yoshimura, T., Yuhki, N., Moore, S.K., Appella, E., Lerman, M.I., and Leonard, E.J., 1989, Human monocyte chemoattractant protein-1 (MCP-1). Full-lenght cDNA cloning, expression in mitogen-stimulation blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE. FEBS Letters, 244: 487.
Zachariae, C.O.C., Anderson, A.O., Thompson, H.L., Appella, E., Mantovani, A., Oppenheim, J.J. and Matsushima, K., 1990, Properties of monocyte chemotactic and activating factor (MCAF) purified from a human fibrosarcoma cell line. J. Exp. Med., 171: 2177.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer Science+Business Media New York
About this chapter
Cite this chapter
Mantovani, A. et al. (1993). Biological Significance and Therapeutic Potential of Tumor-Associated Leukocytes. In: Garaci, E., Goldstein, A.L. (eds) Combination Therapies 2. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2964-4_11
Download citation
DOI: https://doi.org/10.1007/978-1-4615-2964-4_11
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6289-0
Online ISBN: 978-1-4615-2964-4
eBook Packages: Springer Book Archive